PDCD1 and cancer: It could also be speculated that the frequency of exhausted PD-1+ T cell subpopulations that can be reinvigorated by anti-PD-1 blockade may differ between individuals based on the presence of certain PD-1 germline polymorphisms but functional effects of PD1.3 in the cancer setting remains to be established.